Open Innovation at $25 Billion AstraZeneca

Scott Wilkins of AstraZeneca and his colleague Rob Albert discuss the roots of the open innovation program at AstraZeneca and more.

May 18, 2016 · 1 min read

How Open Innovation Got Started at AstraZeneca Scott Wilkins : It really started back in 2010. We were looking to build our pipeline up, to replenish the [products on the market] that were coming off patents. There was a gap there, and we needed a step change in the way we did…